Inactive Instrument

Genzyme Corporation Share Price

Stocks

End-of-day quote Nasdaq Other stock markets
- ^USD	-

28/06/11	GENZYME CORP.GNL : Mipomersen Data Presented at European Atherosclerosis Society Congress	PU
07/03/11	GENZYME CORP.GNL : Genzyme Board Unanimously Recommends that Shareholders Accept sanofi-aventis Revised Offer and Tender Shares	BU
01/03/11	GENZYME CORP.GNL : Genzyme Completes Sale of Pharmaceuticals Business to International Chemical Investors Group	BU
28/02/11	GENZYME CORP.GNL : Genzyme Recognizes International Rare Disease Day by Launching New Patient Advocacy Grant Program	BU
18/02/11	GENZYME CORP.GNL : Three-Year Data from Phase 2 Trial of Genzyme Gaucher Disease Oral Compound Suggest Sustained or Further Improvement Across All Endpoints	BU

28/06/11	SANOFI : Sanofi/Mipomersen efficace dans l'hypercholestérolémie
04/04/11	Genzyme : succès de l'OPE de Sanofi-aventis.
07/03/11	Genzyme : Sanofi-aventis modifie son offre.
16/02/11	GENZYME CORP.GNL : Résultat trimestriel de Genzyme dans la fourchette annoncée
16/02/11	Genzyme : racheté par Sanofi-Aventis.

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
WUXI APPTEC CO., LTD.	+3.13%	+13.95%	+64.21%	+94.35%	55.93B
ARGENX SE	-1.39%	-6.15%	+56.05%	+124.73%	54.49B
INSMED INCORPORATED	-0.27%	-5.77%	+6.75%	+433.06%	23.87B
BIONTECH SE	+1.76%	-1.65%	-16.86%	-15.01%	22.86B
WUXI BIOLOGICS (CAYMAN) INC.	+1.77%	+8.53%	+47.87%	-1.54%	20B
GENMAB A/S	+1.94%	+0.21%	+39.31%	-27.77%	17.48B
PHARMAESSENTIA CORPORATION	+10.00%	-4.30%	+208.33%	+370.99%	15.39B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	-2.42%	+10.11%	+47.16%	+700.31%	15.19B
EXELIXIS, INC.	-0.39%	-1.00%	+26.08%	+186.49%	14.02B
Average	+1.55%	+0.40%	+53.21%	+207.29%	26.58B
Weighted average by Cap.	+1.30%	+0.48%	+51.64%	+169.35%

Employees

Sector